Search Results Search Sort by RelevanceMost Recent Case and Commentary Apr 2016 Prenatal Risk Assessment and Diagnosis of Down Syndrome: Strategies for Communicating Well with Patients Eva Schwartz, MD and Kishore Vellody, MD AMA J Ethics. 2016;18(4):359-364. doi: 10.1001/journalofethics.2016.18.4.ecas1-1604. Case and Commentary Dec 2001 Are There Limits to Honoring Diversity? Faith Lagay, PhD Virtual Mentor. 2001;3(12):431-432. doi: 10.1001/virtualmentor.2001.3.12.hlaw1-0112. Case and Commentary Oct 2008 Physician and Parental Decision Making in Newborn Resuscitation, Commentary 2 Frank A. Chervenak, MD and Laurence B. McCullough, PhD Virtual Mentor. 2008;10(10):620-624. doi: 10.1001/virtualmentor.2008.10.10.ccas1-0810. Case and Commentary Sep 2013 Weighing Risks and Benefits of Prescribing Antidepressants during Pregnancy Benjamin C. Silverman, MD and Anne F. Gross, MD Virtual Mentor. 2013;15(9):746-752. doi: 10.1001/virtualmentor.2013.15.9.ecas1-1309. Policy Forum Mar 2018 Who Counts? What Counts? Place and the Limits of Perinatal Mortality Measures Claire Wendland, MD, PhD Perinatal mortality indicators like the maternal mortality ratio mask social determinants of health and undermine reproductive justice. AMA J Ethics. 2018;20(3):278-287. doi: 10.1001/journalofethics.2018.20.3.pfor2-1803. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858.